Mar
31
2009
Does stress damage the brain? In the March 1st issue of Biological Psychiatry, published by Elsevier, a paper by Tibor Hajszan and colleagues provides an important new chapter to this question.
This issue emerged in the 1990’s as an important clinical question with the observation by J. Douglas Bremner and colleagues, then at the VA National Center for Posttraumatic Stress Disorder (PTSD), that hippocampal volume was reduced Continue Reading »
Mar
30
2009
Identifying and treating depression, including increasing physical activity, may improve quality of life and reduce cardiovascular disease and death in African Americans, according to reports presented at the American Heart Association’s 2009 Conference on Nutrition, Physical Activity and Metabolism.
In one study, researchers in the Jackson Heart Study (JHS) found high depressive symptoms were prevalent Continue Reading »
Mar
26
2009
A new drug developed at the University of California, Davis to treat diabetes, hypertension and inflammatory has entered Phase II of human clinical trials to evaluate its efficacy.
Buy accutane The compound, a soluble epoxide hydrolase enzyme (s-EH) inhibitor, is "a first-in-class drug which may treat a suite Continue Reading »
Mar
13
2009
UI psychologist Kim Johnson and colleagues found in their research that when rats are deficient in sodium chloride, common table salt, they shy away from activities they normally enjoy, like drinking a sugary substance or pressing a bar that stimulates a pleasant sensation in their brains.
"Things that normally would be pleasurable for rats didn’t elicit the same degree of relish, which Continue Reading »
Mar
11
2009
Roche (SWX: RO, ROG;OTCQX: RHHBY) and Evotec (FSE: EVT; NASDAQ:EVTC) announced today that they have entered into an agreement for Phase II clinical development of EVT 101 in patients with treatment-resistant depression. The potential value of this transaction exceeds USD 300 million.
Evotec will be responsible for conducting Phase II studies for EVT 101, a compound originally discovered by Roche and developed from discovery Continue Reading »
Mar
11
2009
Certain men age 75 to 80 are unlikely to benefit from routine prostate specific antigen (PSA) testing, according to a Johns Hopkins study published in the April 2009 issue of The Journal of Urology.
The researchers found that men in this age group with PSA levels less than 3 nanograms per milliliter are unlikely to die of or experience aggressive prostate cancer during their remaining life, suggesting that Continue Reading »
Mar
09
2009
A new study in this week??s PLoS Medicine, reports that the risk of suicide increases two to three time on young men 24 years old or less who leave the UK Armed Forces than those remaining in active service or those in the general population.
In the first two years after discharge, the risk seems to increase in the men with short length of service, and those of inferior rank. Just 14 percent Continue Reading »
Mar
08
2009
Do you feel anxious before every dentist appointment? Do you find yourself feeling sick to your stomach or getting sweaty palms? Is getting your child into the dentist chair like pulling teeth?
Though dental anxiety is quite common, the Pennsylvania Dental Association (PDA) reminds the public that this fear can be easily managed, and is even preventable.
For children, Continue Reading »